| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |